Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#54 / 200 Total
CHRO - Chromocell Therapeutics Corp. - Stock Price Chart
TickerCHRO [AMEX]
CompanyChromocell Therapeutics Corp.
CountryUSA
IndustryBiotechnology
Market Cap8.42MEPS (ttm)-1.54
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B7.45EPS Q/Q-165.10%
Dividend-Sales Q/Q-
Insider Own79.53%Inst Own9.90%
Insider Trans0.00%Inst Trans-
Short Float0.31%EarningsMay 29
Analyst Recom1.00Target Price8.50
Avg Volume19.33K52W Range1.06 - 6.00
Chromocell Therapeutics Corp. is a clinical-stage biotech company that engages in the development and commercialization of new therapeutics to alleviate pain. Its clinical focus is to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. The company was founded on March 19, 2021 and is headquartered in Freehold, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Davis Todd CDirectorFeb 21 '24Option Exercise4.8029,167140,00229,167Feb 23 05:15 PM
Friedberg Ezra MDirectorFeb 21 '24Option Exercise4.8020,64199,077520,719Feb 23 05:12 PM
LGVN - Longeveron Inc - Stock Price Chart
TickerLGVN [NASD]
CompanyLongeveron Inc
CountryUSA
IndustryBiotechnology
Market Cap21.84MEPS (ttm)-9.62
P/E-EPS this Y65.59%
Forward P/E-EPS next Y59.54%
PEG-EPS past 5Y-25.24%
P/S22.29EPS next 5Y-
P/B2.85EPS Q/Q26.93%
Dividend-Sales Q/Q96.42%
Insider Own30.62%Inst Own0.79%
Insider Trans18.09%Inst Trans10.40%
Short Float49.91%EarningsMay 14/a
Analyst Recom1.00Target Price12.00
Avg Volume10.22M52W Range0.77 - 35.60
Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hare JoshuaChief Scientific OfficerApr 11 '24Buy2.3542,553100,000633,280Apr 12 07:00 PM
Soffer RockDirectorApr 11 '24Buy2.3531,91575,000208,534Apr 12 07:00 PM
Hashad Mohamed Wa'el AhmedChief Executive OfficerApr 11 '24Buy2.3510,63824,99919,616Apr 12 07:00 PM
Hare JoshuaChief Scientific OfficerApr 10 '24Buy2.35106,383250,000590,727Apr 12 07:00 PM
Soffer RockDirectorApr 10 '24Buy2.35106,383250,000176,619Apr 12 07:00 PM
CGTX - Cognition Therapeutics Inc - Stock Price Chart
TickerCGTX [NASD]
CompanyCognition Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap94.94MEPS (ttm)-0.92
P/E-EPS this Y-7.56%
Forward P/E-EPS next Y-14.05%
PEG-EPS past 5Y-21.09%
P/S-EPS next 5Y-
P/B3.28EPS Q/Q-27.91%
Dividend-Sales Q/Q-
Insider Own15.81%Inst Own17.83%
Insider Trans0.09%Inst Trans-0.77%
Short Float0.64%EarningsMay 07/b
Analyst Recom1.00Target Price9.80
Avg Volume155.81K52W Range0.90 - 2.95
Today 04:11PM Cognition Therapeutics to Host Investor Webcast to Discuss Results from Proof-of-Concept Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer's Disease at 8:30am ET on Monday July 29, 2024 (GlobeNewswire) +12.86%
Jul-02-24 07:30AM Results from Cognition Therapeutics' Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer's Disease Accepted for Presentation at AAIC (GlobeNewswire) +8.98%
May-21-24 07:30AM Cognition Therapeutics Releases New Episode of Conversations Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease (GlobeNewswire) +8.10%
May-07-24 01:53PM CGTX Stock Earnings: Cognition Therapeutics Beats EPS for Q1 2024 (InvestorPlace)
07:30AM Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update (GlobeNewswire)
Apr-29-24 07:30AM Cognition Therapeutics Completes Enrollment in Phase 2 SHIMMER Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies (GlobeNewswire)
Apr-22-24 07:30AM Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer's Disease (GlobeNewswire)
Apr-02-24 07:30AM Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-01-24 07:30AM Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer's Disease on April 12, 2024 (GlobeNewswire)
Mar-27-24 09:31AM Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Cognition Therapeutics, Inc. is a clinical stage neuroscience company which engages in developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as Alzheimer's disease, dry age-related macular degeneration, geographic atrophy and other conditions. The company was founded by Franz F. Hefti, Gilbert M. Rishton, and Susan M. Catalano on August 21, 2007 and is headquartered in Purchase, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ricciardi LisaCEO & PresidentMar 14 '24Buy1.755,7009,975291,345Mar 14 04:34 PM
ATUS - Altice USA Inc - Stock Price Chart
TickerATUS [NYSE]
CompanyAltice USA Inc
CountryUSA
IndustryTelecom Services
Market Cap814.13MEPS (ttm)0.01
P/E129.20EPS this Y49.35%
Forward P/E20.85EPS next Y-52.63%
PEG-EPS past 5Y35.28%
P/S0.09EPS next 5Y-0.20%
P/B-EPS Q/Q-181.51%
Dividend-Sales Q/Q-1.88%
Insider Own55.31%Inst Own52.74%
Insider Trans0.00%Inst Trans2.95%
Short Float12.49%EarningsAug 01/b
Analyst Recom3.05Target Price2.57
Avg Volume3.06M52W Range1.55 - 3.82
Altice USA, Inc. engages in the provision of broadband, pay television, telephony services, proprietary content, and advertising services. Its brands include Optimum, Suddenlink, Optimum Mobile, Altice Business, News 12 Networks, Cheddar News, a4 Advertising, and i24 News. The company was founded by Patrick Drahi in 2001 and is headquartered in Long Island City, NY.
BFRI - Biofrontera Inc - Stock Price Chart
TickerBFRI [NASD]
CompanyBiofrontera Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap6.31MEPS (ttm)-13.10
P/E-EPS this Y78.96%
Forward P/E-EPS next Y90.88%
PEG-EPS past 5Y7.90%
P/S0.19EPS next 5Y-
P/B-EPS Q/Q48.58%
Dividend-Sales Q/Q-9.40%
Insider Own37.98%Inst Own22.79%
Insider Trans0.00%Inst Trans-
Short Float1.10%EarningsMay 15/a
Analyst Recom1.00Target Price16.00
Avg Volume53.78K52W Range0.61 - 12.75
Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company is focused on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.
ACU - Acme United Corp. - Stock Price Chart
TickerACU [AMEX]
CompanyAcme United Corp.
CountryUSA
IndustryHousehold & Personal Products
Market Cap159.54MEPS (ttm)4.92
P/E8.85EPS this Y24.66%
Forward P/E14.83EPS next Y5.76%
PEG0.89EPS past 5Y30.24%
P/S0.83EPS next 5Y10.00%
P/B1.61EPS Q/Q13.68%
Dividend1.35%Sales Q/Q3.92%
Insider Own12.56%Inst Own63.28%
Insider Trans-5.27%Inst Trans-0.52%
Short Float1.01%EarningsJul 19/b
Analyst Recom1.00Target Price50.00
Avg Volume20.45K52W Range25.01 - 50.99
Acme United Corp. is engaged in the supply of cutting devices, measuring instruments, and safety products for school, home, office, hardware and industrial use. The firm offers its products under the brands Camillus, Clauss, Cuda, DMT Sharpeners, First Aid Only, Med-Nap, Pac-Kit, Physicianscare, Spill Magic, Westcott, Western, and First Aid Central. It operates through the following geographical segments: United States, Canada, and Europe. The company was founded in 1867 and is headquartered in Shelton, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JOHNSEN WALTER CChairman and CEOJul 22 '24Option Exercise16.9240,000676,800351,944Jul 24 04:30 PM
OLSCHAN BRIAN SPresident and COOJul 22 '24Option Exercise20.7913,255275,61051,392Jul 24 04:30 PM
DRISCOLL PAUL GChief Financial OfficerJul 22 '24Option Exercise16.9215,000253,80063,898Jul 24 04:30 PM
OLSCHAN BRIAN SPresident and COOMay 21 '24Option Exercise21.491,21926,19642,322May 23 04:30 PM
OLSCHAN BRIAN SPresident and COOMay 21 '24Sale40.301,21949,12641,103May 23 04:30 PM
CLLS - Cellectis ADR - Stock Price Chart
TickerCLLS [NASD]
CompanyCellectis ADR
CountryFrance
IndustryBiotechnology
Market Cap165.81MEPS (ttm)-1.05
P/E-EPS this Y64.21%
Forward P/E-EPS next Y11.89%
PEG-EPS past 5Y1.69%
P/S32.26EPS next 5Y-
P/B1.83EPS Q/Q109.36%
Dividend-Sales Q/Q3157.55%
Insider Own3.93%Inst Own13.55%
Insider Trans0.00%Inst Trans-2.53%
Short Float0.64%EarningsMay 28/a
Analyst Recom1.57Target Price6.57
Avg Volume64.14K52W Range0.96 - 3.77
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and Andre Choulika on February 20, 1999 and is headquartered in Paris, France.
AVTR - Avantor Inc. - Stock Price Chart
TickerAVTR [NYSE]
CompanyAvantor Inc.
CountryUSA
IndustrySpecialty Chemicals
Market Cap17.39BEPS (ttm)0.38
P/E66.91EPS this Y-5.45%
Forward P/E21.11EPS next Y20.97%
PEG7.60EPS past 5Y-
P/S2.53EPS next 5Y8.80%
P/B3.26EPS Q/Q-50.56%
Dividend-Sales Q/Q-5.65%
Insider Own2.57%Inst Own98.44%
Insider Trans-0.16%Inst Trans-3.85%
Short Float3.24%EarningsJul 26/b
Analyst Recom1.83Target Price27.63
Avg Volume8.25M52W Range16.63 - 26.16
Avantor, Inc. engages in providing mission critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. It operates through the following geographical segments: the Americas, Europe, and AMEA. The company was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Eck Steven WSVP & Chief Accounting OfficerMar 08 '24Sale25.633,68594,44734,406Mar 12 04:46 PM
Couturier ChristopheEVP, AMEAFeb 29 '24Sale24.5313,074320,70583,889Mar 01 04:42 PM
Bramwell JamesEVP Sales, Customer ExcellenceFeb 29 '24Sale24.524,910120,39396,233Mar 01 04:46 PM
Bramwell JamesEVP Sales, Customer ExcellenceFeb 27 '24Sale24.496,203151,911101,143Feb 27 05:02 PM
Eck Steven WSVP & Chief Accounting OfficerSep 07 '23Sale20.647,577156,38928,187Sep 07 05:01 PM
PACB - Pacific Biosciences of California Inc - Stock Price Chart
TickerPACB [NASD, RUT]
CompanyPacific Biosciences of California Inc
CountryUSA
IndustryMedical Devices
Market Cap581.49MEPS (ttm)-1.14
P/E-EPS this Y25.31%
Forward P/E-EPS next Y22.33%
PEG-EPS past 5Y-9.76%
P/S2.90EPS next 5Y-1.00%
P/B0.90EPS Q/Q20.24%
Dividend-Sales Q/Q-0.23%
Insider Own3.03%Inst Own96.96%
Insider Trans-1.88%Inst Trans-6.30%
Short Float23.35%EarningsAug 07/a
Analyst Recom2.13Target Price3.33
Avg Volume9.95M52W Range1.16 - 13.70
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Farmer MicheleSee RemarksMay 20 '24Sale2.035,27510,708211,941May 22 05:25 PM
ORDONEZ KATHYDirectorMar 15 '24Option Exercise2.87361,6211,038,682380,216Mar 19 04:24 PM
Meline David WDirectorMar 06 '24Buy4.4040,000176,16040,000Mar 06 05:36 PM
HENRY CHRISTIAN OSee RemarksMar 04 '24Sale4.8714,17769,0562,596,670Mar 06 05:12 PM
Van Oene MarkSee RemarksMar 04 '24Sale4.879,18644,7451,668,826Mar 06 05:26 PM
EFSH - 1847 Holdings LLC - Stock Price Chart
TickerEFSH [AMEX]
Company1847 Holdings LLC
CountryUSA
IndustryConglomerates
Market Cap1.62MEPS (ttm)-1517.07
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y6.75%
P/S0.02EPS next 5Y-
P/B-EPS Q/Q75.91%
Dividend-Sales Q/Q-3.18%
Insider Own3.06%Inst Own0.32%
Insider Trans0.00%Inst Trans-
Short Float1.97%Earnings-
Analyst Recom-Target Price-
Avg Volume60.67K52W Range1.81 - 299.00
1847 Holdings LLC engages in the acquisition and management of small businesses in different industries. It operates through the following segments: Retail and Appliances, Construction, and Automotive Supplies. The Retail and Appliances segment provides a wide variety of appliance services including sales, delivery, installation, service and repair, extended warranties, and financing. The Construction segment offers doors, door frames, base boards, crown molding, cabinetry, bathroom sinks and cabinets, bookcases, built-in closets, and fireplace mantles. The Automotive Supplies segment designs and sells horn and safety products and provides vehicle emergency and safety warning lights for cars, trucks, industrial equipment, and emergency vehicles. The company was founded by Ellery W. Roberts on January 22, 2013 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roberts ElleryChairman and CEOSep 07 '23Buy0.0770,0004,945616,430Sep 07 04:14 PM
Roberts ElleryChairman and CEOAug 23 '23Buy0.1240,0004,680546,430Aug 23 04:16 PM
Roberts ElleryChairman and CEOAug 22 '23Buy0.1435,0004,795506,430Aug 23 04:16 PM
Strategic Risk, LLC.10% OwnerAug 17 '23Buy0.1473,62910,0803,894,507Aug 17 01:37 PM
Roberts ElleryChairman and CEOAug 16 '23Buy0.1435,0004,900471,430Aug 17 04:01 PM
123456789101120